Dyadic and Medytox To Develop Vaccines Against COVID-19 Variants
22 mars 2021 08h30 HE
|
Dyadic International, Inc.
Expanding existing COVID-19 vaccine research collaboration which began in July 2020.Medytox and Dyadic to co-develop C1 enabled COVID-19 vaccines and/or boosters which will immunize people against two...